Rebalancing T Cells in AD: A Conversation With Dr. Emma Guttman-Yassky on Rocatinlimab’s Potential October 10, 2025
Register Now: Inaugural H&W Global Dermatology CME Conference to Address Global Burden of Eczema October 9, 2025
TDD Expert Reaction: U.S. FDA Approves Roflumilast Cream 0.05% for AD in Kids Aged 2 to 5 Featuring Dr. Lawrence Eichenfield October 8, 2025
NEA to Hold Capitol Hill Policy Summit to Reform Step Therapy, Reduce Prior Authorization Burdens October 8, 2025
Targeting IL-22 in AD: A Q&A About LEO Pharma’s Temtokibart With Michael Ardern-Jones October 1, 2025